Other combinations of markers used in conjunction with CD180, such as CD148 and CD200 (Miguet et al. 2015) or CD148 alone (Gautam et al. 2021), have been suggested to be useful for distinguishing MZL from other malignancies such as mantle cell lymphoma (MCL). Here, PTPRJ is linked to mantle cell lymphoma.